Gastric mucin
Need Assistance?
  • US & Canada:
    +
  • UK: +

Gastric mucin

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Gastric mucin is a large glycoprotein that is thought to play an important role in protecting the gastrointestinal tract from acids, proteases, pathogenic microorganisms and mechanical damage.

Category
Peptide Inhibitors
Catalog number
BAT-010489
CAS number
84082-64-4
Synonyms
Gastron; Mucin type I; ucin type II; ucin type III; ucin type I-S; Gastric Mucin porcine
Appearance
Powder
Purity
≥97%
Storage
Store at 2-8°C
Solubility
Soluble in 1M NaOH (20 mg/mL)
1. Regulation of mucin and glycoconjugate expression: from normal epithelium to gastric tumors
F X Real, C de Bolos, A Lopez-Ferrer Front Biosci . 2001 Oct 1;6:D1256-63. doi: 10.2741/bolos.
Gastric epithelium is protected by a mucus layer rich in MUC5AC and MUC6 mucins synthesised by the superficial epithelium and the glands, respectively. These cell populations also express specific fucosyltransferases that determine the glycosylation pattern of these gastric mucins. The maintenance of the structure and properties of the gastric mucus has been related to the degree of glycosylation and the oligomeric forms of the mucins. In gastric tumors, and in early preneoplastic lesions such as intestinal metaplasia, the glycosylation pattern detected in normal stomach is lost and, intestinal mucins, MUC2 and MUC4, can be ectopically detected in the gastric epithelium. These changes are biologically relevant because the binding of Helicobacter pylori to the gastric mucosa is mediated by blood group-related antigens. In vitro and animal models allowing the study of the gastric ecological niche and the requirements for its maintenance are essential for an understanding of the role of bacterial-mucosal interactions in pathological processes such as inflammation and cancer.
2. Higher gastric mucin secretion and lower gastric acid output in first-degree relatives of gastric cancer patients
Sara Morgenstern, Bracha Hadad, Britta Hardi, Haim Shmuely, Eyal Gal, Yaron Niv, Zohar Levi, Alexander Vilkin J Clin Gastroenterol . 2008 Jan;42(1):36-41. doi: 10.1097/MCG.0b013e3181574d39.
Background:Patients infected by Helicobacter pylori who have first-degree relatives with gastric cancer have an 8-fold increased risk of developing gastric cancer themselves. Mucins are high-molecular-weight glycoproteins that play a cardinal role in the protective mechanism of the gastric epithelium.Aim:To study gastric acid and mucin secretion in dyspeptic patients with and without a family history of gastric cancer and H. pylori infection.Materials and methods:Twenty-six dyspeptic patients underwent esophago-gastro-duodenoscopy, gastric biopsies, and acid and mucin secretory tests. The sample was divided by family history of gastric cancer and H. pylori status.Results:Patients who were infected by H. pylori had a significantly higher degree of inflammation than those who were not. H. pylori-positive patients with a positive family history had a lower basal and maximal gastric acid output than infected patients with no family history and noninfected controls, and a higher basal and maximal mucin output than infected patients with no family history. MUC5AC was the major mucin species expressed in gastric juice.Conclusions:In patients with relatives with gastric cancer, H. pylori infection is associated with a more severe inflammatory reaction consisting of decreased gastric acid secretion and increased mucin secretion.
3. Helicobacter pylori and gastric mucin expression: A systematic review and meta-analysis
Yaron Niv World J Gastroenterol . 2015 Aug 21;21(31):9430-6. doi: 10.3748/wjg.v21.i31.9430.
Aim:To investigate the relationship between Helicobacter pylori (H. pylori) and mucin expression in gastric mucosa.Methods:English Medical literature searches were conducted for gastric mucin expression in H. pylori infected people vs uninfected people. Searches were performed up to December 31(th) 2014, using MEDLINE, PubMed, EMBASE, Scopus, and CENTRAL. Studies comparing mucin expression in the gastric mucosa in patients positive and negative for H. pylori infection, were included. Meta-analysis was performed by using Comprehensive meta-analysis software (Version 3, Biostat Inc., Englewood, NJ, United States). Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated compared mucin expression in individual studies by using the random effects model. Heterogeneity between studies was evaluated using the Cochran Q-test, and it was considered to be present if the Q-test P value was less than 0.10. I(2) statistic was used to measure the proportion of inconsistency in individual studies, with I(2) > 50% representing substantial heterogeneity. We also calculated a potential publication bias.Results:Eleven studies, which represent 53 sub-studies of 15 different kinds of mucin expression, were selected according to the inclusion criteria. Every kind of mucin has been considered as one study. When a specific mucin has been studied in more than one paper, we combined the results in a nested meta-analysis of this particular mucin: MUC2, MUC6, STn, Paradoxical con A, Tn, T, Type 1 chain mucin, LeA, SLeA, LeB, AB-PAS, MUC1, and MUC5AC. The odds ratio of mucin expression in random analysis was 2.33, 95%CI: 1.230-4.411, P = 0.009, higher expression in H. pylori infected patients. Odds ratio for mucin expression in H. pylori positive patients was higher for MUC6 (9.244, 95%CI: 1.567-54.515, P = 0.014), and significantly lower for MUC5AC (0.447, 95%CI: 0.211-0.949, P = 0.036). Thus, H. pylori infection may increase MUC6 expression and decrease MUC5AC expression by 924% and 52%, respectively.Conclusion:H. pylori inhibits MUC5AC expression in the gastric epithelium, and facilitates colonization. In contrast, increased MUC6 expression may help inhibiting colonization, using MUC6 antibiotics properties.
Online Inquiry
Verification code
Inquiry Basket